LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Exact Sciences Corp

Closed

Sector Healthcare

59.09 -2.6

Overview

Share price change

24h

Current

Min

59.05

Max

59.63

Key metrics

By Trading Economics

Income

94M

-16M

Sales

61M

699M

EPS

-0.09

Profit margin

-2.261

Employees

6,500

EBITDA

81M

35M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+32.68 upside

Dividends

By Dow Jones

Next Earnings

30 paź 2024

Market Stats

By TradingEconomics

Market Cap

231M

11B

Previous open

61.69

Previous close

59.09

News Sentiment

By Acuity

11%

89%

11 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Exact Sciences Corp Chart

Related News

9 maj 2024, 19:18 UTC

Earnings

These Stocks Are Moving the Most Today: Roblox, Duolingo, AppLovin, Exact Sciences, AMC, and More -- Barrons.com

9 maj 2024, 15:12 UTC

Earnings

These Stocks Are Moving the Most Today: Roblox, AppLovin, Duolingo, Exact Sciences, SolarEdge, and More -- Barrons.com

Peer Comparison

Price change

Exact Sciences Corp Forecast

Price Target

By TipRanks

32.68% upside

12 Months Forecast

Average 78.43 USD  32.68%

High 100 USD

Low 67 USD

Based on 14 Wall Street analysts offering 12 month price targets forExact Sciences Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

14

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

57.13 / 59.7Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

11 / 365 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Exact Sciences Corp

Exact Sciences Corporation is a cancer screening and diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) scan.